Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Moderna Slumps Premarket; Regeneron and Qualcomm Rise

Published 11/04/2021, 07:57 AM
© Reuters

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Thursday, November 4th. Please refresh for updates.

  • Moderna (NASDAQ:MRNA) stock slumped 11% after the vaccine maker cut its full-year sales forecast for its Covid-19 vaccine to between $15 billion and $18 billion from $20 billion, amid difficulties with the production of its two-dose inoculation.

  • Regeneron (NASDAQ:REGN) stock rose 2.4% after the biotech company reported that its third-quarter profit nearly doubled, boosted by strong sales of its drugs, including its Covid-19 antibody offering.

  • IBM (NYSE:IBM) stock fell 3.6% after the tech giant completed the spin-off of its IT services section, around 25% of its overall business, in a battle to arrest a decade of decline. 
  • Booking Holdings (NASDAQ:BKNG) stock rose 4.6% after the company beat third-quarter sales and profit estimates as travel rebounded during the July-September quarter.

  • Qualcomm (NASDAQ:QCOM) stock rose 9% after the chipmaker’s fourth-quarter earnings were boosted by robust demand for chips from various consumer industries. Goldman Sachs (NYSE:GS) also upgraded its stance to ‘buy’ from ‘neutral’.

  • Cigna (NYSE:CI) stock rose 1.9% after the medical insurer reported better-than-expected third-quarter profit and raised its full-year adjusted profit forecast, helped by growth in its health services unit.

  • Albemarle (NYSE:ALB) stock rose 4.5% as surging demand for lithium and specialty chemicals boosted sales and margins during the chemical manufacturer’s third quarter.

  • ViacomCBS (NASDAQ:VIAC) stock rose 0.5% after the media giant posted better-than-expected quarterly revenue, helped by more subscriber additions to its streaming platforms and strong advertising sales.

  • Merck (NYSE:MRK) stock rose 3.2% after the U.K. became the first country in the world to approve the drugmaker’s Covid-19 antiviral pill.

  • GameStop (NYSE:GME) stock fell 0.1% after the video game retailer, and former retail favorite, entered into a new $500 million global asset-based revolving credit facility with a syndicate of banks.

  • Capri Holdings (NYSE:CPRI) stock rose 5.5% after JPMorgan (NYSE:JPM) upgraded its investment stance to ‘overweight’ from ‘neutral’, saying the fashion holding company’s stock can rise another 20%.

  • MGM Resorts (NYSE:MGM) stock rose 3.3% after the casino operator announced plans to sell the operations of its Mirage casino in Las Vegas to another unnamed company.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.